SCHEMBL21880315

SCHEMBL21880315

COc1c(C)cc(C(=O)O)cc1Cl

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPMT P51580 4/20 0.69
ALDH1A1 P00352 4/20 0.50
KDM4E B2RXH2 2/20 0.50
GAA P10253 1/20 0.50
PLAU P00749 1/20 0.49
TTR P02766 1/20 0.48
TAS1R3 Q7RTX0 3/20 0.48
TAS1R1 Q7RTX1 3/20 0.48
TAS1R2 Q8TE23 3/20 0.48
HPGD P15428 2/20 0.46
HSD17B10 Q99714 1/20 0.46
HTT P42858 2/20 0.46
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.46
KMT2A Q03164 1/20 0.46
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA3 P07451 1/20 0.44
PKM P14618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1191343 0.88 TPMT (0.79) TPMTALDH1A1KDM4EGAAPLAU
SCHEMBL312132 0.86 TPMT (0.55) TPMTALDH1A1KDM4ETAS1R3TAS1R1
Hydrochloric Acid SCHEMBL11851061 0.84 TPMT (0.53) TPMTALDH1A1KDM4ETAS1R3TAS1R1
SCHEMBL19559634 0.84 TPMT (0.50) TPMTALDH1A1KDM4EGAATAS1R3
SCHEMBL24481314 0.84 ALDH1A1 (0.53) TPMTALDH1A1KDM4EGAATAS1R3
SCHEMBL985914 0.81 TPMT (0.69) TPMTALDH1A1KDM4EGAAPLAU
SCHEMBL9944136 0.81 TAS1R3 (0.65) TPMTALDH1A1KDM4EGAATAS1R3
SCHEMBL9720564 0.81 ALDH1A1 (0.50) TPMTALDH1A1KDM4EGAATAS1R3
SCHEMBL21837048 0.80 TPMT (0.67) TPMTALDH1A1KDM4EGAAPLAU
SCHEMBL10323166 0.80 TPMT (0.67) TPMTALDH1A1KDM4EGAAPLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10875848-B2 Inhibiting fatty acid synthase (FASN) FORMA THERAPEUTICS, INC. (US) 2020-12-29 US disclosed
US-20200115368-A1 INHIBITING FATTY ACID SYNTHASE (FASN) FORMA THERAPEUTICS, INC. 2020-04-16 US disclosed
EP-3636637-A1 INHIBITING FATTY ACID SYNTHASE (FASN) Forma Therapeutics, Inc. (US) 2020-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10875848-B2 Inhibiting fatty acid synthase (FASN) FASN, SCD, FADS1 TPMT 1614/4885ALDH1A1 1168/4885KDM4E 3899/4885
US-20200115368-A1 INHIBITING FATTY ACID SYNTHASE (FASN) FASN, SCD, FADS1 TPMT 1614/4885ALDH1A1 1168/4885KDM4E 3899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.